Compare CORT & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | ZGN |
|---|---|---|
| Founded | 1998 | 1910 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | 2001 | 2021 |
| Metric | CORT | ZGN |
|---|---|---|
| Price | $79.84 | $13.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $96.50 | $11.28 |
| AVG Volume (30 Days) | 903.5K | ★ 1.3M |
| Earning Date | 04-30-2026 | 03-20-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | $5.17 |
| Revenue Next Year | $26.98 | $7.89 |
| P/E Ratio | ★ N/A | $25.94 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $7.61 |
| 52 Week High | $91.00 | $15.44 |
| Indicator | CORT | ZGN |
|---|---|---|
| Relative Strength Index (RSI) | 73.56 | 49.27 |
| Support Level | $78.07 | $9.89 |
| Resistance Level | $90.00 | $15.44 |
| Average True Range (ATR) | 3.43 | 0.48 |
| MACD | 0.05 | -0.17 |
| Stochastic Oscillator | 70.32 | 8.08 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of revenue from the Zegna segment.